시장보고서
상품코드
1762278

소프트젤 캡슐 시장 규모, 점유율, 동향, 산업 분석 보고서 : 유형별, 용도별, 최종 용도별, 지역별 - 시장 예측(2025-2034년)

Softgel Capsules Market Size, Share, Trends, Industry Analysis Report: By Type, Application, End Use, and Region - Market Forecast, 2025-2034

발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 120 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 소프트젤 캡슐 세계 시장 규모는 2034년까지 167억 5,000만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

소프트젤 캡슐 시장은 일반적으로 젤라틴 또는 채식 대체물로 만들어지고 액체 또는 반고체 충전재를 포함하는 부드럽고 유연한 외피가 특징인 캡슐 형태의 생산, 유통 및 소비를 포괄합니다. 이러한 캡슐은 의약품, 영양 보충제, 화장품의 바람직한 전달 방법으로 작용하며, 삼키기 쉬움, 생체 이용률 향상, 불쾌한 맛과 냄새를 숨기는 능력 등의 이점을 제공합니다. 이 시장은 다양한 치료 분야와 소비자의 건강 요구를 충족시키는 다양한 용도가 특징입니다.

시장 개요를 살펴보면, 예방적 건강관리에 대한 소비자의 인식 증가, 캡슐화 기술 발전, 노인 인구 증가 등을 배경으로 역동적인 양상을 보이고 있음을 알 수 있습니다. 영양 보충제에 대한 수요 증가와 제약 업계의 약물전달 시스템 강화에 주력하는 제약 업계의 노력으로 시장 확대가 가속화되고 있습니다. 소프트젤 캡슐의 주요 시장 동향으로는 채식주의자를 위한 소프트젤의 채택, 맞춤형 제형, 위탁 제조 조직의 확대 등이 있습니다. 또한, 시장은 엄격한 규제 기준의 영향을 받고 있으며, 고품질의 신뢰할 수 있는 소프트젤 솔루션의 필요성이 경쟁 환경을 형성하고 기술 혁신을 촉진하고 있습니다.

소프트젤 캡슐 시장 보고서 하이라이트

유형별로는 젤라틴 기반/동물성 기반 소프트젤 부문이 제약 및 건강기능식품 분야에서 오랜 기간 동안 사용되어 왔고 비용 효율성이 높아 소프트젤 캡슐 시장에서 큰 점유율을 차지하고 있습니다. 이러한 우위는 잘 구축된 제조 인프라와 규제 프레임워크에 의해 뒷받침되고 있습니다.

용도별로는 비타민 및 영양 보충제 분야가 가장 큰 시장 점유율을 차지하고 있으며, 예방적 건강 및 웰빙을 추구하는 소비자의 확산이 이를 주도하고 있습니다. 소프트젤 캡슐의 복용 편의성과 효능에 대한 인식이 이러한 보충제 시장에서 지속적인 우위를 점하는 데 기여하고 있습니다.

최종 용도별로는 제약회사가 가장 큰 시장 점유율을 차지하고 있으며, 이는 다양한 치료 영역에서 약물전달을 위해 소프트젤 캡슐이 널리 사용되고 있기 때문입니다. 제약회사의 확립된 제조 인프라와 엄격한 품질 관리 프로세스는 고품질의 소프트젤 캡슐 제조를 보장합니다.

지역별로는 북미가 현재 가장 큰 시장 점유율을 차지하고 있으며, 탄탄한 제약 산업과 건강보조식품의 높은 소비자 보급률을 특징으로 합니다. 아시아태평양 시장은 빠르게 성장하는 헬스케어 부문과 가처분 소득 증가에 힘입어 가장 높은 성장률을 보이고 있습니다.

소프트젤 캡슐 시장에서 활동하는 주요 기업으로는 Catalent, Inc., Lonza Group AG, Robinson Pharma, Inc., Captek Softgel International, Inc., Sirio Pharma Co., Ltd., Softigel (Procaps Group S.A.), Aenova Holding GmbH, EuroCaps Ltd. 등이 있습니다.

목차

제1장 소개

제2장 주요 요약

제3장 조사 방법

제4장 세계의 소프트젤 캡슐 시장 인사이트

  • 시장 현황
  • 소프트젤 캡슐 시장 역학
    • 성장 촉진요인과 기회
      • 식이보충제와 식이보충제 수요 증가
      • 생체이용률과 약물전달 향상
    • 성장 억제요인과 과제
      • 젤라틴 공급원에 관한 우려
  • PESTEL 분석
  • 소프트젤 캡슐 시장 애플리케이션 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 소프트젤 캡슐 시장 : 유형별

  • 주요 조사 결과
  • 소개
  • 젤라틴 기반/동물 기반
  • 비동물 기반

제6장 세계의 소프트젤 캡슐 시장 : 용도별

  • 주요 조사 결과
  • 소개
  • 제산제 및 과식방지제
  • 항빈혈제
  • 항염증제
  • 항생제 및 항균제
  • 기침 및 감기약
  • 건강보조제
  • 비타민 및 식이보충제
  • 임신

제7장 세계의 소프트젤 캡슐 시장 : 최종 용도별

  • 주요 조사 결과
  • 소개
  • 제약회사
  • 뉴트라슈티컬 회사
  • 화장품 회사
  • 계약 제조 조직

제8장 세계의 소프트젤 캡슐 시장 : 지역별

  • 주요 조사 결과
  • 소개
    • 소프트젤 캡슐 시장 분석 : 지역별, 2020-2034년
  • 북미
    • 북미 : 유형별, 2020-2034년
    • 북미 : 용도별, 2020-2034년
    • 북미 : 최종 용도별, 2020-2034년
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 유형별, 2020-2034년
    • 유럽 : 용도별, 2020-2034년
    • 유럽 : 최종 용도별, 2020-2034년
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 유형별, 2020-2034년
    • 아시아태평양 : 용도별, 2020-2034년
    • 아시아태평양 : 최종 용도별, 2020-2034년
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 유형별, 2020-2034년
    • 중동 및 아프리카 : 용도별, 2020-2034년
    • 중동 및 아프리카 : 최종 용도별, 2020-2034년
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 남아프리카공화국
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 유형별, 2020-2034년
    • 라틴아메리카 : 용도별, 2020-2034년
    • 라틴아메리카 : 최종 용도별, 2020-2034년
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제9장 경쟁 구도

  • 확대와 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제10장 기업 개요

  • Aenova Holding GmbH
  • Captek Softgel International, Inc.
  • Catalent, Inc.
  • EuroCaps Ltd.
  • Lonza Group AG
  • Robinson Pharma, Inc.
  • Sirio Pharma Co., Ltd.
  • Softigel(Procaps Group S.A.)
ksm 25.07.09

The global softgel capsules market size is expected to reach USD 16.75 billion by 2034, according to a new study by Polaris Market Research. The report "Softgel Capsules Market Size, Share, Trends, Industry Analysis Report: By Type (Gelatin-Based/Animal-Based and Non-Animal-Based), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The softgel capsules market encompasses the production, distribution, and consumption of encapsulated dosage forms featuring a soft, pliable outer shell, typically made from gelatin or vegetarian alternatives, containing liquid or semi-solid fill materials. These capsules serve as a preferred delivery method for pharmaceuticals, nutraceuticals, and cosmeceuticals, offering advantages such as ease of swallowing, improved bioavailability, and the ability to mask unpleasant tastes or odors. The market is characterized by a diverse range of applications, catering to various therapeutic areas and consumer health needs.

An overview of the market reveals a dynamic landscape driven by increasing consumer awareness of preventive healthcare, technological advancements in encapsulation, and the growing geriatric population. The rising demand for dietary supplements, coupled with the pharmaceutical industry's focus on enhancing drug delivery systems, is propelling market expansion. Key softgel capsules market trends include the adoption of vegetarian softgels, customized formulations, and the expansion of contract manufacturing organizations. The market is also influenced by stringent regulatory standards and the need for high-quality, reliable softgel solutions, shaping the competitive environment and driving innovation.

Softgel Capsules Market Report Highlights

By type, the gelatin-based/animal-based softgels segment holds a larger softgel capsules market share due to their long-established use and cost-effectiveness in pharmaceutical and nutraceutical applications. This dominance is supported by well-established manufacturing infrastructures and regulatory frameworks.

By application, the vitamin & dietary supplement segment commands the largest market share, driven by widespread consumer adoption for preventative health and wellness. The ease of consumption and perceived efficacy of softgel capsules in delivering these supplements contribute to their sustained market dominance.

By end use, the pharmaceutical companies segment holds the largest market share, driven by the extensive use of softgel capsules for drug delivery across various therapeutic areas. Their established manufacturing infrastructure and rigorous quality control processes ensure the production of high-quality softgel capsules.

By region, North America currently holds the largest market share, characterized by a robust pharmaceutical industry and high consumer adoption of dietary supplements. The Asia Pacific market is experiencing the highest growth rate, driven by a rapidly expanding healthcare sector and increasing disposable incomes.

Key players active in the softgel capsules market include Catalent, Inc.; Lonza Group AG; Robinson Pharma, Inc.; Captek Softgel International, Inc.; Sirio Pharma Co., Ltd.; Softigel (Procaps Group S.A.); Aenova Holding GmbH; and EuroCaps Ltd.

Polaris Market Research has segmented the market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue-USD Billion, 2020-2034)

Gelatin-Based/Animal-Based

Non-Animal-Based

By Application Outlook (Revenue-USD Billion, 2020-2034)

Antacid & Anti-Flatulent Preparation

Anti-Anemic Preparations

Anti-Inflammatory Drugs

Antibiotic & Antibacterial Drugs

Cough & Cold Preparations

Health Supplement

Vitamin & Dietary Supplement

Pregnancy

By End Use Outlook (Revenue-USD Billion, 2020-2034)

Pharmaceutical Companies

Nutraceutical Companies

Cosmeceutical Companies

Contract Manufacturing Organizations

By Regional Outlook (Revenue-USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of the Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Softgel Capsules Market Insights

  • 4.1. Softgel Capsules Market - Market Snapshot
  • 4.2. Softgel Capsules Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Demand for Dietary Supplements and Nutraceuticals
      • 4.2.1.2. Enhanced Bioavailability and Drug Delivery
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Gelatin source concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Softgel Capsules Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Softgel Capsules Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Gelatin-Based/Animal-Based
    • 5.3.1. Global Softgel Capsules Market, by Gelatin-Based/Animal-Based, by Region, 2020-2034 (USD Billion)
  • 5.4. Non-Animal-Based
    • 5.4.1. Global Softgel Capsules Market, by Non-Animal-Based, by Region, 2020-2034 (USD Billion)

6. Global Softgel Capsules Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Antacid & Anti-Flatulent Preparation
    • 6.3.1. Global Softgel Capsules Market, by Antacid & Anti-Flatulent Preparation, by Region, 2020-2034 (USD Billion)
  • 6.4. Anti-Anemic Preparations
    • 6.4.1. Global Softgel Capsules Market, by Anti-Anemic Preparations, by Region, 2020-2034 (USD Billion)
  • 6.5. Anti-Inflammatory Drugs
    • 6.5.1. Global Softgel Capsules Market, by Anti-Inflammatory Drugs, by Region, 2020-2034 (USD Billion)
  • 6.6. Antibiotic & Antibacterial Drugs
    • 6.6.1. Global Softgel Capsules Market, by Antibiotic & Antibacterial Drugs, by Region, 2020-2034 (USD Billion)
  • 6.7. Cough & Cold Preparations
    • 6.7.1. Global Softgel Capsules Market, by Cough & Cold Preparations, by Region, 2020-2034 (USD Billion)
  • 6.8. Health Supplement
    • 6.8.1. Global Softgel Capsules Market, by Health Supplement, by Region, 2020-2034 (USD Billion)
  • 6.9. Vitamin & Dietary Supplement
    • 6.9.1. Global Softgel Capsules Market, by Vitamin & Dietary Supplement, by Region, 2020-2034 (USD Billion)
  • 6.10. Pregnancy
    • 6.10.1. Global Softgel Capsules Market, by Pregnancy, by Region, 2020-2034 (USD Billion)

7. Global Softgel Capsules Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
  • 7.3. Pharmaceutical Companies
    • 7.3.1. Global Softgel Capsules Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
  • 7.4. Nutraceutical Companies
    • 7.4.1. Global Softgel Capsules Market, by Nutraceutical Companies, by Region, 2020-2034 (USD Billion)
  • 7.5. Cosmeceutical Companies
    • 7.5.1. Global Softgel Capsules Market, by Cosmeceutical Companies, by Region, 2020-2034 (USD Billion)
  • 7.6. Contract Manufacturing Organizations
    • 7.6.1. Global Softgel Capsules Market, by Contract Manufacturing Organizations, by Region, 2020-2034 (USD Billion)

8. Global Softgel Capsules Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Softgel Capsules Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Softgel Capsules Market - North America
    • 8.3.1. North America: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.3.4. Softgel Capsules Market - U.S.
      • 8.3.4.1. U.S.: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.3.5. Softgel Capsules Market - Canada
      • 8.3.5.1. Canada: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
  • 8.4. Softgel Capsules Market - Europe
    • 8.4.1. Europe: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.4.4. Softgel Capsules Market - UK
      • 8.4.4.1. UK: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.4.5. Softgel Capsules Market - France
      • 8.4.5.1. France: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.4.6. Softgel Capsules Market - Germany
      • 8.4.6.1. Germany: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.4.7. Softgel Capsules Market - Italy
      • 8.4.7.1. Italy: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.4.8. Softgel Capsules Market - Spain
      • 8.4.8.1. Spain: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.4.9. Softgel Capsules Market - Netherlands
      • 8.4.9.1. Netherlands: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.4.10. Softgel Capsules Market - Russia
      • 8.4.10.1. Russia: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.4.11. Softgel Capsules Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
  • 8.5. Softgel Capsules Market - Asia Pacific
    • 8.5.1. Asia Pacific: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.5.4. Softgel Capsules Market - China
      • 8.5.4.1. China: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.5.5. Softgel Capsules Market - India
      • 8.5.5.1. India: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.5.6. Softgel Capsules Market - Malaysia
      • 8.5.6.1. Malaysia: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.5.7. Softgel Capsules Market - Japan
      • 8.5.7.1. Japan: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.5.8. Softgel Capsules Market - Indonesia
      • 8.5.8.1. Indonesia: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.5.9. Softgel Capsules Market - South Korea
      • 8.5.9.1. South Korea: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.5.10. Softgel Capsules Market - Australia
      • 8.5.10.1. Australia: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.5.11. Softgel Capsules Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
  • 8.6. Softgel Capsules Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.6.4. Softgel Capsules Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.6.5. Softgel Capsules Market - UAE
      • 8.6.5.1. UAE: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.6.6. Softgel Capsules Market - Israel
      • 8.6.6.1. Israel: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.6.7. Softgel Capsules Market - South Africa
      • 8.6.7.1. South Africa: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.6.8. Softgel Capsules Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
  • 8.7. Softgel Capsules Market - Latin America
    • 8.7.1. Latin America: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.7.4. Softgel Capsules Market - Mexico
      • 8.7.4.1. Mexico: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.7.5. Softgel Capsules Market - Brazil
      • 8.7.5.1. Brazil: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.7.6. Softgel Capsules Market - Argentina
      • 8.7.6.1. Argentina: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
    • 8.7.7. Softgel Capsules Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Aenova Holding GmbH
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Captek Softgel International, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Catalent, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. EuroCaps Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Lonza Group AG
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Robinson Pharma, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Sirio Pharma Co., Ltd.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Softigel (Procaps Group S.A.)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제